Divisadero Street Capital Management, LP Eton Pharmaceuticals, Inc. Transaction History
Divisadero Street Capital Management, LP
- $1.65 Billion
- Q3 2025
A detailed history of Divisadero Street Capital Management, LP transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Divisadero Street Capital Management, LP holds 298,000 shares of ETON stock, worth $5.04 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
298,000
Previous 497,716
40.13%
Holding current value
$5.04 Million
Previous $7.09 Million
8.28%
% of portfolio
0.39%
Previous 0.64%
Shares
2 transactions
Others Institutions Holding ETON
# of Institutions
104Shares Held
15.9MCall Options Held
103KPut Options Held
0-
Opaleye Management Inc. Boston, MA2.86MShares$48.3 Million10.4% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$34.3 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$19.9 Million1.04% of portfolio
-
Morgan Stanley New York, NY586KShares$9.9 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $428M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...